1. Welcome to our
Presentation
WE ARE TEAM EXODUS

3. Our team members
Md.Khalad Sams - 1420588030
Md. Abu Bakar Siddike- 1530596030
Salman Sifat- 1210278030
Tanvir Hasan- 1610915630
K.M. Abdulla Al Galib- 1611671630
Md.Ashraful huq- 1611512630

4. Introduction
Company profile :
 Beximco Pharma was founded in 1976 and started operations in 1980,
 the licenses of Bayer AG of Germany and Upjohn Inc. of United States.
 it supplies more than 10% of country's total medicinal needs.
 manufactures and markets its own branded generics for several diseases
including AIDS, cancer, asthma, hypertension, and diabetes for both national and
international markets
 first drug company from Bangladesh to sell its products in the US.

5. Planning
Mission:
 We are committed to enhancing human health and
well-being by providing contemporary and affordable
medicines, manufactured in full compliance with
global quality standards. We continually strive to
improve our core capabilities to address the unmet
medical needs of the patients and to deliver
outstanding results for our shareholders

6. Vision
 We will be one of the most trusted, admired and
successful pharmaceutical companies in the region
with a focus on strengthening research and
development capabilities, creating partnerships and
building presence across the globe.

7. Focus of the company
 Satisfying the needs of their customers, both internal
and external.
 Ensuring highest quality standards of its products.
 Giving high priority on building capabilities of their
employees and empower them to realize their full
potential.
 They take great care in managing their operations with
high concern for safety and environment.

8. SWOT Analysis
A company’s internal (Strength, Weakness) and external (Opportunity, Threat) analysis is
combinedly called swot analysis.
Strengths:
• Strong Brand Image and favorable corporate image.
• Created job opportunities for 48000 employees.
• They maintain a standard quality of their products.
Weakness:
• It has multiple industries and companies. So sometimes they can’t focus properly on
their pharmaceuticals sector.
• The company does not have sufficient working capital.
• Excessive overhead cost, and hence low profit margin.

9. SWOT Analysis
Opportunities:
•Faster market growth.
•Opportunity to enter in the biggest market like US market.
•Government regulations are in favor of local manufactures.
Threats:
•Intense competition.
•Highly regulated market.
•Strong competitors are working on backward linkage for API (Active Pharmaceutical
Ingredients) production.

10. Organizational Structure of Beximco
Pharma
Board Of Directors Managing Director (MD)
Deputy Managing Director (DMG) Executive Vice President
Senior Vice President (SVP) Vice President (VP)
Senior Assistant Vice President (SAVP) Assistant Vice President (AVP)
Senior Executive Officer (SEO) Executive Officer.
Principal Officer. Senior Officer
Officer. Junior Officer.

11. Area of operation
 Beximco is the largest exporter of medicines. They operates mainty from
 Tongi, Gazipur, Bangladesh.
 The exports to:
 TGA Australia,
 AGES Austria (for the European Union)
 Health Canada
 ANVISA Brazil
 INVIMA Colombia and TFDA (Taiwan) etc

12. Recruitment Process
1. Need Assessment 2. Defining the position description
3. Checking the recruiting options 4. Advertisement
5. Screening and Short – listing Applications 6. Written test
7. Selection interview (3 – tier) 8. Employment decision (Application Bank)
9. Pre- employment medical check-up 10. Offer letter
11. Orientation / Induction 12. Placement
13. Follow –up

13. Human resource management and
Administration
 Beximco Pharmaceuticals Ltd (Beximco Pharma) is an emerging generic drug
player committed to providing access to affordable medicines. Company’s state-
of-the-art manufacturing facilities have been accredited by the regulatory
authorities of Australia, European Union, Canada, and Brazil, among others, and
it currently focuses on building a presence in many emerging and developed
markets around the world. Beximco Pharma is consistently building upon its
portfolio and currently producing more than 500 products encompassing broad
therapeutic categories and the Company has created strong differentiation by
offering a range of high-tech, specialized products which are difficult to imitate.

14. Training & Development
TRAINING METHOD
•On-The-Job Training
Informal Training
Lectures
Simulated Training
•Off-The-Job Training
Case Study Method
Outside Seminars

15. Training & Development
Types of Training
 Technical Training
 Management Training
 Safety Training
 Workers' Education Training etc.
Training Process
 Identifying the training needs
 Analyzing the attributes, skills & knowledge of the job
 Planning the training program & implementing
 Evaluating the results

16. Training & Development
Employee Development Method
 Job Rotation: Moving employees from department to department to broaden their
understanding of all parts of the business and test their abilities.
 Coaching Approach: Making employees work directly with a senior manager.
 Action Learning: Allowing employees to work full-time analyzing and solving
problems in other departments as well.

17. Motivation
Motivating Employees
 Education costs of the children for some certain level of employees
 Permanent job facility
 Leave facilities
 Yearly employee awards
 Promotions
 Foreign travel with family
 Shares from revenue etc.

18. Information System
Beximco Pharma's MIS has some components.
 The internal environment.
 Databases.
 Applications and software.
 Administrative supports.

19. Management Issues
 ENERGY
 STANDARDS OF PERFORMANCE
 EXERTING PRESSURE
 LISTENING FOR INSIGHTS
 CONTROL OF DETAILS
 COOPERATION

20. Company Standard
1. IN THE DOMESTIC MARKET, BEXIMCO PHARMA RANKS SECOND AMONG
MORE THAN 200 PHARMACEUTICAL COMPANIES.
2. BEING ONE OF THE LARGEST EXPORTERS OF PHARMACEUTICALS IN
THE COUNTRY, THE COMPANY HAS GROWING PRESENCE IN 45
COUNTRIES ACROSS AFRICA, LATIN AMERICA, ASIA, MIDDLE EAST AND
CENTRAL AMERICA.
3.BESIDES MAJOR RETAIL OUTLETS, BEXIMCO PHARMA'S PRODUCTS ARE
BEING SUPPLIED TO RENOWNED HOSPITALS AND INSTITUTIONS LIKE
RAFFLES HOSPITAL, HEALTHWAY MEDICAL GROUP AND, K K WOMEN &
CHILDREN HOSPITAL IN SINGAPORE.
4.IT HAS MADE SIGNIFICANT INVESTMENT IN BUILDING CAPABILITIES,
BOTH INFRASTRUCTURE AND HUMAN RESOURCES, TO CAPITALIZE ON
THE GENERIC DRUG OPPORTUNITIES IN THE DEVELOPED MARKETS LIKE
EU AND US.

21. Company Objective
 ACHIEVED SALES TURNOVER OF BDT 12,965.51 MILLION WITH A
GROWTH OF 15.7% OVER 2014.
 BECAME THE FIRST BANGLADESHI PHARMACEUTICAL COMPANY TO
BE APPROVED BY THE US FOOD & DRUG ADMINISTRATION.
 TO INTRODUCE WIDER PRODUCT LINE AND SUPERIOR ON TIME
DELIVERY.
 CONTINUOUS LEARNING AND DEVELOPING A LEARNING
ORGANIZATION.
 EXPLORE AND KEEP ON EXPLORING NEW MARKETS FOR
PRODUCTS.
 INCREASE NETWORKING WITH PARTNERS.
 TO CONTRIBUTE TO THE PERSONAL WELLBEING OF ITS
EMPLOYEES.
 NET SALES GREW BY 13.1% TO TK.7,069 MILLION.

22. Supply Chain Management

23. ISO 9001
 ISO 9001 is a certified quality management system which is
internationally recognized.
Standards of ISO 9001:
 Customer focus & satisfaction
 Process approach.
 Systems approach to management.
 Continual improvement.
 Factual approach to decision making.

24. Beximco Pharma's
Approval
 Beximco Pharma's core values of putting the "quality" first and
upholding the innovation to achieve the customer’s mind.
 The product of this company is ISO 9001: 2000 certified.
 Beximco Pharma has been audited properly and approved by:
 National Health Surveillance Agency (ANVISA)
 Therapeutic Goods Administration (TGA)
 Qualified by UNICEF (MDI & OSD)
 Qualified by Asthma Drug Facility (ADF)
 Qualified by Global GlaxoSmithKline (MDI)

26. Conclusion
 Beximco Pharmaceuticals Ltd. is a leading edge company & is the
largest exporter of pharmaceuticals from Bangladesh.
 Besides, it’s the company to win National Export Trophy (Gold),
national acclamation for export for three times.
 Beximco succeeded in gaining trust & confidence of the doctors and
patients all over the country.
 The company is consistently going ahead day by day & I believe it
will gain a competitive edge.